Who makes C52R1L, C52R1M?

C52R1L, C52R1M is developed by AJU Pharm Co., Ltd..

Last reviewed 2026-04-23 · How we verify

C52R1L, C52R1M

AJU Pharm Co., Ltd. · Phase 3 active Small molecule

C52R1L and C52R1M are investigational drugs with unknown mechanisms of action.

At a glance

Generic name	C52R1L, C52R1M
Sponsor	AJU Pharm Co., Ltd.
Modality	Small molecule
Phase	Phase 3

Mechanism of action

Further research is needed to understand how these drugs work mechanistically.

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Efficacy and Safety of AJU-C52 in Essential Hypertension Patients (PHASE3)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

C52R1L, C52R1M CI brief — competitive landscape report
C52R1L, C52R1M updates RSS · CI watch RSS
AJU Pharm Co., Ltd. portfolio CI